期刊
BMJ CASE REPORTS
卷 15, 期 5, 页码 -出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/bcr-2021-247888
关键词
Dermatology; Haematology (incl blood transfusion); Mouth; Transplantation
In this case study, a young adult male with primary refractory Hodgkin's lymphoma developed cutaneous GvHD after stem cell transplantation and required immunosuppressive treatment. However, the patient also developed tongue lesions consistent with chronic GvHD, which were successfully resolved with Janus-associated kinase inhibitor therapy.
Graft-versus-host disease (GvHD) is a potentially life-threatening and commonly encountered event of allogeneic haematopoietic stem cell transplantation. Here, we present a young adult male with primary refractory Hodgkin's lymphoma who received a transplant and developed cutaneous GvHD after donor lymphocyte infusion, which was managed with cyclosporine and steroids. However, while the patient was under immunosuppressive treatment, diffuse confluent whitish patches on the patient's tongue were observed. A biopsy of the tongue lesions revealed lichenoid, hyperkeratotic tissue changes and intraepithelial T-cell infiltration consistent with chronic GvHD. He was treated with mycophenolate mofetil for 6 months with minimal improvement. Janus-associated kinase inhibitor (ruxolitinib) treatment was commenced, with complete resolution of the tongue lesions and treatment discontinuation 5 months later. Currently, 5 years after allogeneic transplantation, he is in remission and does not need immunosuppressive therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据